Nosyk B, Min JE, Homayra F, Kurz M, Guerra-Alejos BC, Yan R, Piske M, Seaman SR, Bach P, Greenland S, Karim ME, Siebert U, Bruneau J, Gustafson P, Kampman K, Korthuis PT, Loughin T, McCandless LC, Platt RW, Schnepel KT, Socías ME. Buprenorphine/Naloxone vs Methadone for the Treatment of Opioid Use Disorder , JAMA: 2024
Thakrar AP, Christine PJ, Siaw-Asamoah A, Spadaro A, Faude S, Snider CK, Delgado MK, Lowenstein M, Kampman K, Perrone J, Nelson LS, Kilaru AS. Buprenorphine-Precipitated Withdrawal Among Hospitalized Patients Using Fentanyl , JAMA Netw Open, 7: 2024,e2435895
Shi Z, Li X, Kampman KM, Childress AR, Wiers CE, Langleben DD. Depressive Symptomatology Is Associated With Smaller Reductions in Drug Cue Reactivity During Extended-Release Naltrexone Treatment of Opioid Use Disorder , J Clin Psychiatry, 84: 2023,22br14567
Stewart RE, Cardamone NC, Mandell DS, Kwon N, Kampman KM, Knudsen HK, Tjoa CW, Marcus SC. Not in my treatment center: Leadership's perception of barriers to MOUD adoption , J Subst Abuse Treat: 2023
French R, Worley J, Lowenstein M, Bogner HR, Calderbank T, DePhilippis D, Forrest A, Connolly Gibbons MB, Harris RA, Heywood S, Kampman K, Mandell DS, McKay JR, Newman ST, Oslin DW, Wadden S, Wolk CB. Adapting psychotherapy in collaborative care for treating opioid use disorder and co-occurring psychiatric conditions in primary care , Fam Syst Health: 2023
Dugosh KL, Lent MR, Burkley SB, Millard CMK, McKay JR, Kampman KM. Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine Treatment , J Addict Med: 2023
Krouse RA, Morales KH, Kampman KM, Chakravorty S. The role of baseline insomnia in moderating the hypnotic properties of quetiapine , Addict Behav: 2023
114., Kuijper MF, Mahajan UV, Ku S, Barbosa DAN, Alessi SM, Stein SE, Kampman KM, Bentzley BS, Halpern CH Deep Brain Stimulation Compared With Contingency Management for the Treatment of Cocaine Use Disorders: A Threshold and Cost-Effectiveness Analysis , Neuromodulation , 25(2): 2022
Lynch KG, Plebani, J, Spratt K, Morales M, Tamminga M, Feibush P, Kampman KM. Varenicline for the Treatment of Cocaine Dependence J addict , J addict. Med, 16(2): 2022
Lynch KG, Plebani, J, Spratt K, Morales M, Tamminga M, Feibush P, Kampman KM. Varenicline for the Treatment of Cocaine Dependence J addict , J addict. Med, 16(2): 2022
